|
1
|
Adeshara KA, Diwan AG and Tupe RS:
Diabetes and complications: Cellular signaling pathways, current
understanding and targeted therapies. Curr Drug Targets.
17:1309–1328. 2016. View Article : Google Scholar
|
|
2
|
Yuan CM, Nee R, Ceckowski KA, Knight KR
and Abbott KC: Diabetic nephropathy as the cause of end-stage
kidney disease reported on the medical evidence form CMS2728 at a
single center. Clin Kidney J. 10:257–262. 2017.PubMed/NCBI
|
|
3
|
Chen B, Li Y, Liu Y and Xu Z: circLRP6
regulates high glucose-induced proliferation, oxidative stress, ECM
accumulation, and inflammation in mesangial cells. J Cell Physiol.
234:21249–21259. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marciano DK: Mesangial Cells: The tuft
guys of glomerular development. J Am Soc Nephrol. 30:1551–1553.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abboud HE: Mesangial cell biology. Exp
Cell Res. 318:979–985. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Zhao Q, Jin X, Li Y and Song J:
Silencing of LncRNA PVT1 inhibits the proliferation, migration and
fibrosis of high glucose-induced mouse mesangial cells via
targeting microRNA-93-5p. Biosci Rep. 40:402020.
|
|
7
|
Zhang L, Liu J, Zhou F, Wang W and Chen N:
PGC-1α ameliorates kidney fibrosis in mice with diabetic kidney
disease through an antioxidative mechanism. Mol Med Rep.
17:4490–4498. 2018.PubMed/NCBI
|
|
8
|
Zhao JH: Mesangial cells and renal
fibrosis. Adv Exp Med Biol. 1165:165–194. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Buhl EM, Djudjaj S, Klinkhammer BM, Ermert
K, Puelles VG, Lindenmeyer MT, Cohen CD, He C, Borkham-Kamphorst E,
Weiskirchen R, et al: Dysregulated mesenchymal PDGFR-β drives
kidney fibrosis. EMBO Mol Med. 12:e110212020. View Article : Google Scholar
|
|
10
|
Yuan P, Xue H, Zhou L, Qu L, Li C, Wang Z,
Ni J, Yu C, Yao T, Huang Y, et al: Rescue of mesangial cells from
high glucose-induced over-proliferation and extracellular matrix
secretion by hydrogen sulfide. Nephrol Dial Transplant.
26:2119–2126. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang R: Physiological implications of
hydrogen sulfide: A whiff exploration that blossomed. Physiol Rev.
92:791–896. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu M, Li Y, Liang B, Li Z, Jiang Z, Chu C
and Yang J: Hydrogen sulfide attenuates myocardial fibrosis in
diabetic rats through the JAK/STAT signaling pathway. Int J Mol
Med. 41:1867–1876. 2018.
|
|
13
|
Dugbartey GJ: Diabetic nephropathy: A
potential savior with 'rotten-egg' smell. Pharmacol Rep.
69:331–339. 2017. View Article : Google Scholar
|
|
14
|
Feliers D, Lee HJ and Kasinath BS:
Hydrogen sulfide in renal physiology and disease. Antioxid Redox
Signal. 25:720–731. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Missale C, Nash SR, Robinson SW, Jaber M
and Caron MG: Dopamine receptors: From structure to function.
Physiol Rev. 78:189–225. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beaulieu JM, Espinoza S and Gainetdinov
RR: Dopamine receptors -IUPHAR Review 13. Br J Pharmacol. 172:1–23.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Beaulieu JM and Gainetdinov RR: The
physiology, signaling, and pharmacology of dopamine receptors.
Pharmacol Rev. 63:182–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bryson SE, Drew GM, Hall AS, Ball SG and
Balmforth AJ: Characterization of the dopamine receptor expressed
by rat glomerular mesangial cells in culture. Eur J Pharmacol.
225:1–5. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang G, Wu L, Jiang B, Yang W, Qi J, Cao
K, Meng Q, Mustafa AK, Mu W, Zhang S, et al: H2S as a
physiologic vaso-relaxant: Hypertension in mice with deletion of
cystathionine gamma-lyase. Science. 322:587–590. 2008. View Article : Google Scholar
|
|
20
|
Li HZ, Han LP, Jiang CM, Li H, Zhao YJ,
Gao J, Lin Y, Ma SX, Tian Y, Yang BF, et al: Effect of dopamine
receptor 1 on apoptosis of cultured neonatal rat cardiomyocytes in
simulated ischaemia/reperfusion. Basic Clin Pharmacol Toxicol.
102:329–336. 2008. View Article : Google Scholar
|
|
21
|
Zhou X, Feng Y, Zhan Z and Chen J:
Hydrogen sulfide alleviates diabetic nephropathy in a
streptozotocin-induced diabetic rat model. J Biol Chem.
289:28827–28834. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Waz S, Heeba GH, Hassanin SO and
Abdel-Latif RG: Nephroprotective effect of exogenous hydrogen
sulfide donor against cyclophosphamide-induced toxicity is mediated
by Nrf2/HO-1/NF-κB signaling pathway. Life Sci. 264:1186302021.
View Article : Google Scholar
|
|
23
|
Yang G, Tang G, Zhang L, Wu L and Wang R:
The pathogenic role of cystathionine γ-lyase/hydrogen sulfide in
streptozotocin-induced diabetes in mice. Am J Pathol. 179:869–879.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen B, Li W, Lv C, Zhao M, Jin H, Jin H,
Du J, Zhang L and Tang X: Fluorescent probe for highly selective
and sensitive detection of hydrogen sulfide in living cells and
cardiac tissues. Analyst (Lond). 138:946–951. 2013. View Article : Google Scholar
|
|
25
|
Olson KR, Gao Y, Arif F, Patel S, Yuan X,
Mannam V, Howard S, Batinic-Haberle I, Fukuto J, Minnion M, et al:
Manganese porphyrin-based SOD mimetics produce polysulfides from
hydrogen sulfide. Antioxidants. 8:82019. View Article : Google Scholar
|
|
26
|
Papadopoulou-Marketou N, Paschou SA,
Marketos N, Adamidi S, Adamidis S and Kanaka-Gantenbein C: Diabetic
nephropathy in type 1 diabetes. Minerva Med. 109:218–228. 2018.
View Article : Google Scholar
|
|
27
|
Drummond K and Mauer M; International
Diabetic Nephropathy Study Group: The early natural history of
nephropathy in type 1 diabetes: II. Early renal structural changes
in type 1 diabetes. Diabetes. 51:1580–1587. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bithi N, Link C, Henderson YO, Kim S, Yang
J, Li L, Wang R, Willard B and Hine C: Dietary restriction
transforms the mammalian protein persulfidome in a tissue-specific
and cystathionine γ-lyase-dependent manner. Nat Commun.
12:17452021. View Article : Google Scholar
|
|
29
|
Wang M, Guo Z and Wang S: The effect of
certain conditions in the regulation of cystathionine γ-lyase by
exogenous hydrogen sulfide in mammalian cells. Biochem Genet.
51:503–513. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shankland SJ: Cell cycle regulatory
proteins in glomerular disease. Kidney Int. 56:1208–1215. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee MH and Yang HY: Negative regulators of
cyclin-dependent kinases and their roles in cancers. Cell Mol Life
Sci. 58:1907–1922. 2001. View Article : Google Scholar
|
|
32
|
Thullberg M, Welcker M, Bartkova J,
Kjerulff AA, Lukas J, Högberg J and Bartek J: Monoclonal antibody
probes for p21WAF1/CIP1 and the INK4 family of cyclin-dependent
kinase inhibitors. Hybridoma. 19:63–72. 2000. View Article : Google Scholar
|
|
33
|
Chen JH, Tseng TH, Ho YC, Lin HH, Lin WL
and Wang CJ: Gaseous nitrogen oxides stimulate cell cycle
progression by retinoblastoma phosphorylation via activation of
cyclins/Cdks [correction]. Toxicol Sci. 76:83–90. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chow MJ, Turcotte R, Lin CP and Zhang Y:
Arterial extracellular matrix: A mechanobiological study of the
contributions and interactions of elastin and collagen. Biophys J.
106:2684–2692. 2014. View Article : Google Scholar :
|
|
35
|
Johnson RJ, Floege J, Yoshimura A, Iida H,
Couser WG and Alpers CE: The activated mesangial cell: A glomerular
'myofibroblast'? J Am Soc Nephrol. 2(Suppl 10): S190–S197. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kreisberg JI, Venkatachalam M and Troyer
D: Contractile properties of cultured glomerular mesangial cells.
Am J Physiol. 249:F457–F463. 1985.PubMed/NCBI
|
|
37
|
Ohtomo S, Nangaku M, Izuhara Y, Yamada N,
Dan T, Mori T, Ito S, van Ypersele de Strihou C and Miyata T: The
role of megsin, a serine protease inhibitor, in diabetic mesangial
matrix accumulation. Kidney Int. 74:768–774. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Z, Gao H, Wang L, Ma X, Tian L, Zhao
W, Li K, Zhang Y, Ma F, Lu J, et al: Farrerol alleviates high
glucose-induced renal mesangial cell injury through the
ROS/Nox4/ERK1/2 pathway. Chem Biol Interact. 316:1089212020.
View Article : Google Scholar
|
|
39
|
Mao Q, Chen C, Liang H, Zhong S, Cheng X
and Li L: Astragaloside IV inhibits excessive mesangial cell
proliferation and renal fibrosis caused by diabetic nephropathy via
modulation of the TGF-β1/Smad/miR-192 signaling pathway. Exp Ther
Med. 18:3053–3061. 2019.PubMed/NCBI
|
|
40
|
Qian X, He L, Hao M, Li Y, Li X, Liu Y,
Jiang H, Xu L, Li C, Wu W, et al: YAP mediates the interaction
between the Hippo and PI3K/Akt pathways in mesangial cell
proliferation in diabetic nephropathy. Acta Diabetol. 58:47–62.
2021. View Article : Google Scholar
|
|
41
|
Cargnello M and Roux PP: Activation and
function of the MAPKs and their substrates, the MAPK-activated
protein kinases. Microbiol Mol Biol Rev. 75:50–83. 2011. View Article : Google Scholar :
|
|
42
|
Bramanti V, Grasso S, Tibullo D, Giallongo
C, Raciti G, Viola M and Avola R: Modulation of extracellular
signal-related kinase, cyclin D1, glial fibrillary acidic protein,
and vimentin expression in estradiol-pretreated astrocyte cultures
treated with competence and progression growth factors. J Neurosci
Res. 93:1378–1387. 2015. View Article : Google Scholar
|
